SCTL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SCTL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Societal CDMO's Average Total Inventories for the three months ended in Dec. 2023 was $11.27 Mil. Societal CDMO's Cost of Goods Sold for the three months ended in Dec. 2023 was $20.02 Mil. Hence, Societal CDMO's Days Inventory for the three months ended in Dec. 2023 was 51.37.
The historical rank and industry rank for Societal CDMO's Days Inventory or its related term are showing as below:
During the past 13 years, Societal CDMO's highest Days Inventory was 116.86. The lowest was 49.06. And the median was 87.08.
Societal CDMO's Days Inventory declined from Dec. 2022 (51.59) to Dec. 2023 (51.37).
Inventory Turnover measures how fast the company turns over its inventory within a year. Societal CDMO's Inventory Turnover for the three months ended in Dec. 2023 was 1.78.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Societal CDMO's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.41.
The historical data trend for Societal CDMO's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Societal CDMO Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 92.25 | 89.96 | 67.46 | 52.29 | 49.06 |
Societal CDMO Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Inventory | Get a 7-Day Free Trial | 51.59 | 51.77 | 64.34 | 57.72 | 51.37 |
For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Days Inventory distribution charts can be found below:
* The bar in red indicates where Societal CDMO's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Societal CDMO's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (10.301 | + | 10.262) | / | 2 ) | / | 76.497 | * | 365 |
= | 10.2815 | / | 76.497 | * | 365 | ||||
= | 49.06 |
Societal CDMO's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (12.279 | + | 10.262) | / | 2 ) | / | 20.021 | * | 365 / 4 |
= | 11.2705 | / | 20.021 | * | 365 / 4 | ||||
= | 51.37 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Societal CDMO (NAS:SCTL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Societal CDMO's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 20.021 | / | 11.2705 | |
= | 1.78 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Societal CDMO's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 11.2705 | / | 27.719 | |
= | 0.41 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Societal CDMO's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Bryan M. Reasons | director | C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544 |
Elena Cant | director | C/O SOCIETAL CDMO, INC., 1 E. UWCHLAN AVENUE, SUITE 112, EXTON PA 19341 |
Enloe J David Jr | director, officer: Chief Executive Officer | |
James Charles Miller | director | 490 LAPP ROAD, MALVERN PA 19355 |
Wayne Weisman | director | 490 LAPP ROAD, MALVERN PA 19355 |
William Ashton | director | C/O HARRISON CONSULTING GROUP, PO BOX 283, NEWTOWN SQUARE PA 19073 |
Winston J Churchill | director | C/O SCP PARTNERS, SUITE 300, 1200 LIBERTY RIDGE DRIVE, WAYNE PA 19087 |
Awm Investment Company, Inc. | 10 percent owner | 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022 |
Mathew Paul Arens | director, 10 percent owner | C/O FIRST LIGHT ASSET MANAGEMENT, LLC, 3300 EDINBOROUGH WAY, SUITE 201, EDINA MN 55435 |
First Light Asset Management, Llc | director, 10 percent owner | 3300 EDINBOROUGH WAY, SUITE 201, EDINA MN 55435 |
Laura L. Parks | director | C/O RECRO PHARMA, INC., 490 LAPP ROAD, MALVERN PA 29355 |
Michael Berelowitz | director | 415 EAST 37TH STREET, APT 36C, NEW YORK NY 10016 |
Ryan David Lake | officer: Chief Financial Officer | KENSEY NASH CORPORATION, 735 PENNSYLVANIA DRIVE, EXTON PA 19341 |
Scp Vitalife Partners (israel) Ii, L.p. | 10 percent owner | SUITE 190, 7 GREAT VALLEY PARKWAY, MALVERN PA 19355 |
Scp Vitalife Partners Ii Lp | 10 percent owner | SUITE 190, 7 GREAT VALLEY PARKWAY, MALVERN PA 19355 |
From GuruFocus
By Marketwired • 09-07-2023
By Marketwired • 10-05-2023
By Marketwired • 08-23-2023
By Marketwired • 08-23-2023
By Stock market mentor Stock market mentor • 01-06-2023
By sperokesalga sperokesalga • 04-12-2023
By sperokesalga sperokesalga • 05-09-2023
By Stock market mentor Stock market mentor • 02-01-2023
By sperokesalga sperokesalga • 05-03-2023
By Marketwired • 08-09-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.